Search for Clinical Trial Results
Idiopathic Inflammatory Myopathy - 26 Studies Found
Status | Study |
Completed |
Study Name: Alemtuzumab to Treat Sporadic Inclusion Body Myositis Condition: Myositis, Inclusion Body Date: 2004-03-12 Interventions: Drug: Alemtuzumab (Campath) |
Not yet recruiting |
Study Name: Study of Arimoclomol in Inclusion Body Myositis (IBM) Condition: Inclusion Body Myositis Date: 2016-04-25 Interventions:
|
Completed |
Study Name: Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis Condition: Inclusion Body Myositis Date: 2009-05-11 |
Active, not recruiting |
Study Name: An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203 Condition: Sporadic Inclusion Body Myositis Date: 2015-07-09 Interventions:
|
Completed |
Study Name: Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis Condition: Inclusion Body Myositis Date: 2008-12-04 Interventions: Drug: Etanercept 50 milligrams subcutaneously every week |
Active, not recruiting |
Study Name: Natalizumab in Inclusion Body Myositis (IBM) Condition: Inclusion Body Myositis (IBM) Date: 2013-05-31 Interventions: Drug: Natalizumab Other Name: Tysabri |
Completed |
Study Name: Blood-flow Restricted Exercise in Inclusion Body Myositis Condition: Sporadic Inclusion Body Myositis Date: 2014-12-10 Interventions:
|
Completed |
Study Name: Treatment With TNF Blockade, Infliximab, in Patients With Myositis Condition: Refractory Myositis Date: 2007-03-02 Interventions: Drug: Infliximab |
Completed |
Study Name: Immune Abnormalities in Sporadic Inclusion Body Myositis Condition:
|
Recruiting |
Study Name: Adult and Juvenile Myositis Condition:
|